Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IMPDH2 | P12268 | 1/20 | 0.38 |
| ▸ | MAOB | P27338 | 8/20 | 0.35 |
| ▸ | EGFR | P00533 | 1/20 | 0.35 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.35 |
| ▸ | KDR | P35968 | 1/20 | 0.35 |
| ▸ | MAOA | P21397 | 2/20 | 0.35 |
| ▸ | AR | P10275 | 2/20 | 0.34 |
| ▸ | MET | P08581 | 1/20 | 0.33 |
| ▸ | HMOX1 | P09601 | 1/20 | 0.33 |
| ▸ | P2RY14 | Q15391 | 1/20 | 0.33 |
| ▸ | PPARA | Q07869 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30938642 | 0.91 | SIRT2 (0.35) | EGFRKDRMETP2RY14PPARA | |
| SCHEMBL29330952 | 0.91 | SIRT2 (0.35) | EGFRKDRMETP2RY14PPARA | |
| SCHEMBL30938633 | 0.91 | SIRT2 (0.35) | EGFRKDRMETP2RY14PPARA | |
| SCHEMBL29330500 | 0.90 | P2RY14 (0.35) | P2RY14 | |
| SCHEMBL29330566 | 0.89 | IMPDH2 (0.50) | IMPDH2MAOBEGFRARMET | |
| SCHEMBL29330502 | 0.88 | KCNH2 (0.39) | KDRMET | |
| SCHEMBL29332780 | 0.86 | MET (0.33) | METPPARA | |
| SCHEMBL29328813 | 0.86 | CDK4 (0.33) | METP2RY14 | |
| SCHEMBL29330428 | 0.85 | ESR1 (0.42) | MAOBEGFRPDGFRBKDR | |
| SCHEMBL29328811 | 0.83 | CDK2 (0.32) | MET |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024151919-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY | IFM DUE, INC. (US) | 2024-07-18 | — | — | WO | disclosed |